0001209191-19-024119.txt : 20190409 0001209191-19-024119.hdr.sgml : 20190409 20190409172418 ACCESSION NUMBER: 0001209191-19-024119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190408 FILED AS OF DATE: 20190409 DATE AS OF CHANGE: 20190409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castellanos Elaine CENTRAL INDEX KEY: 0001662520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 19740151 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-08 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662520 Castellanos Elaine 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Principal Accounting Officer Class A common stock 2019-04-08 4 C 0 2000 A 4138 D Class A common stock 2019-04-08 4 S 0 2000 90.17 D 2138 D Employee Stock Option (right to buy) 11.00 2019-04-08 4 M 0 2000 0.00 D 2026-05-25 Class B common stock 2000 41434 D Class B common stock 2019-04-08 4 M 0 2000 11.00 A Class A common stock 2000 2000 D Class B common stock 2019-04-08 4 C 0 2000 D Class A common stock 2000 0 D The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The options vest in sixteen equal quarterly installments beginning on August 25, 2016. /s/ Michael D. Wortley, attorney-in-fact 2019-04-09